Next Article in Journal
Connecting People with Cancer to Physical Activity and Exercise Programs: A Pathway to Create Accessibility and Engagement
Previous Article in Journal
Prescribing Practices of Endocrine Therapy for Ductal Carcinoma in Situ in British Columbia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 25
Issue 2
10.3747/co.25.3790
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Intravenous Vitamin C in the Supportive Care of Cancer Patients: A Review and Rational Approach

by
E. Klimant
1,
H. Wright
2,
D. Rubin
2,
D. Seely
3 and
M. Markman
4
1
Salish Canc Ctr, Fife, WA, USA
2
Naturopath Specialists, 7331 E Osborne Dr, Scottsdale, AZ 85251, USA
3
Ottawa Integrat Canc Ctr, Dept Res & Clin Epidemiol, Ottawa, ON, Canada
4
Canc Treatment Ctr Amer, Dept Med Oncol, Philadelphia, PA, USA
Curr. Oncol. 2018, 25(2), 139-148; https://doi.org/10.3747/co.25.3790
Submission received: 2 January 2018 / Revised: 3 February 2018 / Accepted: 10 March 2018 / Published: 1 April 2018

Abstract

This article reviews intravenous vitamin C (IV C) in cancer care and offers a rational approach to enable medical oncologists and integrative practitioners to safely provide IV C combined with oral vitamin C to patients. The use of IV C is a safe supportive intervention to decrease inflammation in the patient and to improve symptoms related to antioxidant deficiency, disease processes, and side effects of standard cancer treatments. A proposed rationale, together with relevant clinical safety considerations for the application of IV C in oncologic supportive care, is provided.
Keywords: Vitamin C deficiency; intravenous vitamin C; ascorbate; supportive care; quality of life Vitamin C deficiency; intravenous vitamin C; ascorbate; supportive care; quality of life

Share and Cite

MDPI and ACS Style

Klimant, E.; Wright, H.; Rubin, D.; Seely, D.; Markman, M. Intravenous Vitamin C in the Supportive Care of Cancer Patients: A Review and Rational Approach. Curr. Oncol. 2018, 25, 139-148. https://doi.org/10.3747/co.25.3790

AMA Style

Klimant E, Wright H, Rubin D, Seely D, Markman M. Intravenous Vitamin C in the Supportive Care of Cancer Patients: A Review and Rational Approach. Current Oncology. 2018; 25(2):139-148. https://doi.org/10.3747/co.25.3790

Chicago/Turabian Style

Klimant, E., H. Wright, D. Rubin, D. Seely, and M. Markman. 2018. "Intravenous Vitamin C in the Supportive Care of Cancer Patients: A Review and Rational Approach" Current Oncology 25, no. 2: 139-148. https://doi.org/10.3747/co.25.3790

APA Style

Klimant, E., Wright, H., Rubin, D., Seely, D., & Markman, M. (2018). Intravenous Vitamin C in the Supportive Care of Cancer Patients: A Review and Rational Approach. Current Oncology, 25(2), 139-148. https://doi.org/10.3747/co.25.3790

Article Metrics

Back to TopTop